Literature DB >> 27251742

Regulation of osteosarcoma cell lung metastasis by the c-Fos/AP-1 target FGFR1.

D Weekes, T G Kashima, C Zandueta, N Perurena, D P Thomas, A Sunters, C Vuillier, A Bozec, E El-Emir, I Miletich, A Patiño-Garcia, F Lecanda, A E Grigoriadis.   

Abstract

Entities:  

Year:  2016        PMID： 27251742     DOI： 10.1038/onc.2015.420

Source DB:  PubMed          Journal:  Oncogene        ISSN： 0950-9232            Impact factor:   9.867


× No keyword cloud information.
  12 in total

Review 1.  For robust big data analyses: a collection of 150 important pro-metastatic genes.

Authors:  Yan Mei; Jun-Ping Yang; Chao-Nan Qian
Journal:  Chin J Cancer       Date:  2017-01-21

2.  Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.

Authors:  Qiaozhen Wang; Huancai Liu; Qing Wang; Fenghua Zhou; Yongxin Liu; Yawen Zhang; Haoyu Ding; Meng Yuan; Fengjie Li; Yanchun Chen
Journal:  PLoS One       Date:  2017-06-30       Impact factor: 3.240

3.  miR-200c and phospho-AKT as prognostic factors and mediators of osteosarcoma progression and lung metastasis.

Authors:  Pablo Berlanga; Lisandra Muñoz; Marta Piqueras; J Antoni Sirerol; María Dolors Sánchez-Izquierdo; David Hervás; Miguel Hernández; Margarita Llavador; Isidro Machado; Antonio Llombart-Bosch; Adela Cañete; Victoria Castel; Jaime Font de Mora
Journal:  Mol Oncol       Date:  2016-04-23       Impact factor: 6.603

4.  Functional assessment of von Willebrand factor expression by cancer cells of non-endothelial origin.

Authors:  Anahita Mojiri; Konstantin Stoletov; Maria Areli Lorenzana Carrillo; Lian Willetts; Saket Jain; Roseline Godbout; Paul Jurasz; Consolato M Sergi; David D Eisenstat; John D Lewis; Nadia Jahroudi
Journal:  Oncotarget       Date:  2017-02-21

5.  Recurrent rearrangements of FOS and FOSB define osteoblastoma.

Authors:  Matthew W Fittall; William Mifsud; Nischalan Pillay; Hongtao Ye; Anna-Christina Strobl; Annelien Verfaillie; Jonas Demeulemeester; Lei Zhang; Fitim Berisha; Maxime Tarabichi; Matthew D Young; Elena Miranda; Patrick S Tarpey; Roberto Tirabosco; Fernanda Amary; Agamemnon E Grigoriadis; Michael R Stratton; Peter Van Loo; Cristina R Antonescu; Peter J Campbell; Adrienne M Flanagan; Sam Behjati
Journal:  Nat Commun       Date:  2018-06-01       Impact factor: 14.919

6.  NKX2-2 Suppresses Osteosarcoma Metastasis and Proliferation by Downregulating Multiple Target Genes.

Authors:  Huiming Chen; Wenqiang Liu; Li Zhong; Dan Liao; Ruhua Zhang; Tiebang Kang; Yuanzhong Wu
Journal:  J Cancer       Date:  2018-08-06       Impact factor: 4.207

7.  MicroRNA-761 targets FGFR1 to suppress the malignancy of osteosarcoma by deactivating PI3K/Akt pathway.

Authors:  Zhongzhe Lv; Jinming Ma; Jianchuan Wang; Jianmin Lu
Journal:  Onco Targets Ther       Date:  2019-10-15       Impact factor: 4.147

8.  Gene Prioritization through Consensus Strategy, Enrichment Methodologies Analysis, and Networking for Osteosarcoma Pathogenesis.

Authors:  Alejandro Cabrera-Andrade; Andrés López-Cortés; Gabriela Jaramillo-Koupermann; César Paz-Y-Miño; Yunierkis Pérez-Castillo; Cristian R Munteanu; Humbert González-Díaz; Alejandro Pazos; Eduardo Tejera
Journal:  Int J Mol Sci       Date:  2020-02-05       Impact factor: 5.923

Review 9.  The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.

Authors:  Isabelle Corre; Franck Verrecchia; Vincent Crenn; Francoise Redini; Valérie Trichet
Journal:  Cells       Date:  2020-04-15       Impact factor: 6.600

Review 10.  Oncofetal Chondroitin Sulfate: A Putative Therapeutic Target in Adult and Pediatric Solid Tumors.

Authors:  Nastaran Khazamipour; Nader Al-Nakouzi; Htoo Zarni Oo; Maj Ørum-Madsen; Anne Steino; Poul H Sorensen; Mads Daugaard
Journal:  Cells       Date:  2020-03-28       Impact factor: 6.600
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.